These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 27065335)
1. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling. Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335 [TBL] [Abstract][Full Text] [Related]
2. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1. Cao XZ; Bin H; Zang ZN Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451 [TBL] [Abstract][Full Text] [Related]
3. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830 [TBL] [Abstract][Full Text] [Related]
4. Long Intergenic Nonprotein Coding RNA 173 Inhibits Tumor Growth and Promotes Apoptosis by Repressing Sphingosine Kinase 1 Protein Expression in Pancreatic Cancer. Li Q; Li X; Yang X; Zhang B; Gu Y; Gu G; Xiong J; Li Y; Qian Z DNA Cell Biol; 2021 Jun; 40(6):757-775. PubMed ID: 33978457 [TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway. Xu X; Yu Y; Zong K; Lv P; Gu Y J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504 [TBL] [Abstract][Full Text] [Related]
7. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer. Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer. Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis. Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096 [TBL] [Abstract][Full Text] [Related]
10. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097 [TBL] [Abstract][Full Text] [Related]
11. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma. Chen Q; Wang P; Fu Y; Liu X; Xu W; Wei J; Gao W; Jiang K; Wu J; Miao Y Oncol Rep; 2017 Dec; 38(6):3567-3573. PubMed ID: 29039566 [TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells. Yao C; Ruan JW; Zhu YR; Liu F; Wu HM; Zhang Y; Jiang Q Aging (Albany NY); 2020 Mar; 12(6):5399-5410. PubMed ID: 32203055 [TBL] [Abstract][Full Text] [Related]
15. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling. Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894 [TBL] [Abstract][Full Text] [Related]
18. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y; Ma X; Wang Y; Li G Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210 [TBL] [Abstract][Full Text] [Related]
19. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669 [TBL] [Abstract][Full Text] [Related]
20. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling. Chi H Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]